Filtered By:
Management: Partnerships

This page shows you your search results in order of date. This is page number 14.

Order by Relevance | Date

Total 424 results found since Jan 2013.

Policy Primers: Public Coverage And Prescription Drug Pricing
Health Affairs has released the next set in a series of peer-reviewed health policy briefs on key issues currently shaping the prescription drug market. Each brief offers a short, accessible overview of the issue and a close examination of how it affects pricing. This second set of briefs tell the story of different prescription drug coverage mechanisms (who pays whom and how much), how they interact with other pricing measures, and what future reforms might look like. They are: MEDICARE PART B The Medicare Part B “buy and bill” payment structure for physician-administered drugs also influences private-sector prices. M...
Source: Health Affairs Blog - August 10, 2017 Category: Health Management Authors: Health Affairs Tags: Elsewhere@ Health Affairs Featured Health Policy Briefs Source Type: blogs

MKSAP: 34-year-old man with episodic palpitations
Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians. A 34-year-old man is evaluated for episodic palpitations of 8 months’ duration. The palpitations last 5 to 10 minutes and then resolve spontaneously. They are usually associated with sweating and anxiety. Medical history is significant for thyroidectomy for medullary thyroid carcinoma diagnosed at 12 years of age. His father has also undergone thyroidectomy for medullary thyroid cancer. His only medication is levothyroxine. On physical examination, blood pressure is 164/92 mm Hg, pulse rate is 106/min, and...
Source: Kevin, M.D. - Medical Weblog - July 29, 2017 Category: General Medicine Authors: < a href="http://www.kevinmd.com/blog/post-author/mksap" rel="tag" > mksap < /a > Tags: Conditions Endocrinology Source Type: blogs

Orphan Diseases Or Population Health? Policy Choices Drive Venture Capital Investments
The US exhibits a remarkable pipeline of biopharmaceutical innovation, with 170 new drugs and biologics launched into the market between 2011 and 2015 and another 22 drugs approved in 2016. A striking feature of the pharmaceutical pipeline is the large percentage launched for the treatment of small “orphan” indications, defined by the Food and Drug Administration (FDA) as including fewer than, often many fewer than, 200,000 patients in the United States. Almost half (74) of the products approved by the FDA between 2011 and 2015 were for orphan indications, twice the number (36) approved during the same period by the Eu...
Source: Health Affairs Blog - July 21, 2017 Category: Health Management Authors: Dayton Misfeldt and James C. Robinson Tags: Costs and Spending Drugs and Medical Innovation Orphan Drug Act orphan drugs venture capitalism Source Type: blogs

PhRMA Report Shows More than 240 Immuno-Oncology Treatments in Development
In early June 2017, the Pharmaceutical Research and Manufacturers of America (PhRMA) – in partnership with the American Cancer Society Cancer Action Network (ACS CAN) – released a report that found there are over 240 immuno-oncology medicines and vaccines currently in development. Immuno-oncology treatments are found through research into the role of the body’s immune system in fighting cancer. New immuno-oncology treatment options are allowing the patient’s own immune system to fight cancer similar to the way it fights disease-causing viruses and bacteria. The treatments can help the patient’s own immune system...
Source: Policy and Medicine - July 14, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs

FDA User Fee Reauthorization Poised To Pass House of Representatives
On Monday, the House of Representatives released the latest version of the proposed Food and Drug Administration (FDA) user fee reauthorization bill. The House is expected to vote on the must-pass bill as early as today, but the Senate has not yet set forth its own timeline for voting on the bill. I have previously written here about the version of the bill marked up in the Senate, and about the committee staff’s valiant efforts to keep the bill free of politically controversial provisions. In this post, I review some of the key provisions in the newly released bill and consider its implications for the FDA. Widespread A...
Source: Health Affairs Blog - July 12, 2017 Category: Health Management Authors: Rachel Sachs Tags: Drugs and Medical Innovation FDA orphan drugs user fees Source Type: blogs

The Messenger Also Matters: Value-Based Payment Can Support Outreach To Vulnerable Populations
With the proliferation of value-based payment initiatives and implementation of the Affordable Care Act’s (ACA’s) coverage expansions, states have had many opportunities in recent years to improve the health of vulnerable populations through health promotion, prevention, and care coordination. We believe value-based payment models can and must support accountable health care delivery systems in partnering with community-based “messengers” to engage vulnerable individuals in health education and promotion. We explore one such messenger program, ACCESS, a Brooklyn-based project of the Arthur Ashe Institute for Urban ...
Source: Health Affairs Blog - July 10, 2017 Category: Health Management Authors: Ruth C. Browne, Marilyn Fraser, Judith Killen and Laura Tollen Tags: Health Equity Medicaid and CHIP Population Health Arthur Ashe Institute for Urban Health New York New York State Social Determinants of Health value-based payment vulnerable populations Source Type: blogs

Many patient care decisions are based on a pathologist ’s diagnosis
When Martina Wood received a diagnosis of stage 2 breast cancer, she was scared for her life. She also wanted answers to her questions about the disease and how to best move forward with her treatment. Seventy percent of all patient care decisions are based on a pathologist’s diagnosis, and yet most patients have never met the physicians responsible for guiding their treatment. Follow Martina on her journey for answers, a journey that ultimately leads her to building a partnership with her pathologist. Created by the College of American Pathologists. Your patients are rating you online: How to respond. Manage your online...
Source: Kevin, M.D. - Medical Weblog - July 1, 2017 Category: General Medicine Authors: < a href="http://www.kevinmd.com/blog/post-author/admin" rel="tag" > Admin < /a > Tags: Video Cancer Source Type: blogs

Building Sustainable Partnerships To Improve Access To Breast Cancer Treatment For Uninsured Women
Breast cancer is a terrifying disease for most women. In the United States, it is the leading cause of cancer deaths among women ages twenty to fifty-nine years. More than 5,100 women are diagnosed with—and at least 1,100 women die from—breast cancer in New York City each year. The breast cancer survival rate is also lower for uninsured women than for those with private health insurance coverage. Although access to affordable breast cancer screening and treatment has grown substantially over the past few years as a result of increased health insurance coverage options through the Affordable Care Act (ACA), many uninsur...
Source: Health Affairs Blog - June 20, 2017 Category: Health Management Authors: Kumbirai M. Madondo, Janice Zaballero and José Pagán Tags: Costs and Spending Featured GrantWatch Health Professionals Insurance and Coverage Access breast cancer Consumers Health Care Costs Health Care Delivery Health Philanthropy Health Promotion and Disease PreventionGW Hospitals imag Source Type: blogs

Replicating Effective Models Of Complex Care Management For Older Adults
Improving our system of care for older adults with complex, chronic illnesses requires wrestling with a vexing dilemma. Models of care that are readily scalable have limited effectiveness, and effective models are difficult to scale. As an example of the former, the patient-centered medical home (PCMH) has become widespread, but its impact on population health and health care costs varies and has been modest overall. As a stand-alone solution, the PCMH appears insufficient to deliver the diverse set of interventions required by chronically ill, older adults with complex needs—a growing segment of the US population th...
Source: Health Affairs Blog - June 7, 2017 Category: Health Management Authors: Ken Coburn, Charlotte Grinberg, Sophia Demuynck and Margaret Hawthorne Tags: Costs and Spending Diffusion of Innovation Featured Medicare chronically ill older adults complex care management health and aging Health Quality Partners Source Type: blogs

Top Companies in Genomics
From portable genome sequencers until genetic tests revealing distant relations with Thomas Jefferson, genomics represents a fascinatingly innovative area of healthcare. As the price of genome sequencing has been in free fall for years, the start-up scene is bursting from transformative power. Let’s look at some of the most amazing ventures in genomics! The amazing journey of genome sequencing Genome sequencing has been on an amazing scientific as well as economic journey for the last three decades. The Human Genome Project began in 1990 with the aim of mapping the whole structure of the human genome and sequencing it. ...
Source: The Medical Futurist - May 30, 2017 Category: Information Technology Authors: nora Tags: Genomics Personalized Medicine AI artificial intelligence bioinformatics cancer DNA dna testing DTC gc3 genetic disorders genetics genome sequencing personal genomics precision medicine Source Type: blogs

Interview with Harshal Shah, Head of Oncology Drug Delivery at Cambridge Consultants
Thanks to the ongoing advancements in standards of care and gradual improvements in more targeted therapeutics, some argue that cancer is slowly turning into a chronic disease, and with it bringing about a host of new challenges for oncology care. Th...
Source: Medgadget - May 22, 2017 Category: Medical Devices Authors: Mohammad Saleh Tags: Exclusive Oncology Source Type: blogs

The time is now: Addressing health inequities in rural minority populations
In 1966 Dr. Martin Luther King Jr. gave a speech to the Medical Committee for Human Rights and said “of all the forms of inequality, injustice in healthcare is the most shocking and inhumane.” In 2017 inequality in healthcare still exists and the consequences are striking. Health inequities or disparities in urban communities are well known and in some cases more resources may be available to address them than in a rural community. In rural previously homogenous communities these issues are even more significant as the minority community begins to grow but the healthcare systems have not changed or are not moving fast ...
Source: Disruptive Women in Health Care - May 17, 2017 Category: Consumer Health News Authors: dw at disruptivewomen.net Tags: Uncategorized Source Type: blogs

A Day at The Future of Artificial Intelligence and Machine Learning in Healthcare Conference
At the end of April leaders and innovators from the fields of artificial intelligence and healthcare gathered in Old Street—London’s digital tech hub, affectionately known as “silicon roundabout.” The event was hosted by Innovatemedte...
Source: Medgadget - May 10, 2017 Category: Medical Devices Authors: Tom Peach Tags: Exclusive Source Type: blogs

Update from London Global Forum on Life Science Innovation
The two-day Global Forum on Life Science Innovation came to London last week, bringing together participants from industry, academia, and advocacy charities. The program’s speakers included a number of Directors of Research who set out the pressing...
Source: Medgadget - May 2, 2017 Category: Medical Equipment Authors: Tom Peach Tags: Exclusive Source Type: blogs